Design of the First‐in‐Class, Highly Potent Irreversible Inhibitor Targeting the Menin‐MLL Protein–Protein Interaction

Publisher： John Wiley & Sons Inc

E-ISSN： 1521-3773|57|6|1601-1605

ISSN： 1433-7851

Source： ANGEWANDTE CHEMIE INTERNATIONAL EDITION, Vol.57, Iss.6, 2018-02, pp. : 1601-1605

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Design of the First‐in‐Class, Highly Potent Irreversible Inhibitor Targeting the Menin‐MLL Protein–Protein Interaction

By  

ANGEWANDTE CHEMIE, Vol. 130, Iss. 6, 2018-02 ,pp. : 1617-1621

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stereochemical Assignment of the Protein–Protein Interaction Inhibitor JBIR‐22 by Total Synthesis

By  

ANGEWANDTE CHEMIE, Vol. 127, Iss. 13, 2015-03 ,pp. : 4118-4122

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stereochemical Assignment of the Protein–Protein Interaction Inhibitor JBIR‐22 by Total Synthesis

By  

ANGEWANDTE CHEMIE INTERNATIONAL EDITION, Vol. 54, Iss. 13, 2015-03 ,pp. : 4046-4050

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epitope Targeting of Tertiary Protein Structure Enables Target‐Guided Synthesis of a Potent In‐Cell Inhibitor of Botulinum Neurotoxin

By  

ANGEWANDTE CHEMIE INTERNATIONAL EDITION, Vol. 54, Iss. 24, 2015-06 ,pp. : 7114-7119

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epitope Targeting of Tertiary Protein Structure Enables Target‐Guided Synthesis of a Potent In‐Cell Inhibitor of Botulinum Neurotoxin

By  

ANGEWANDTE CHEMIE, Vol. 127, Iss. 24, 2015-06 ,pp. : 7220-7225

John Wiley & Sons Inc

Access to resources Recommend Favorite